Literature DB >> 8495866

Mechanisms of inhibition by heparin of vascular smooth muscle cell proliferation and migration.

Y P Au1, R D Kenagy, M M Clowes, A W Clowes.   

Abstract

Heparin, an inhibitor of vascular smooth muscle cell proliferation and migration, affects a number of other cell functions. These effects include inhibition of growth factor binding, deposition of matrix proteins and gene expression. Various mechanisms have been proposed and, yet, how heparin works as an inhibitor remains unclear. We have postulated that heparin inhibits smooth muscle cell growth and migration by suppressing the expression of matrix-degrading enzymes such as plasminogen activators and interstitial collagenase. The molecular mechanism of heparin's inhibitory action on these proteases is currently under investigation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8495866     DOI: 10.1159/000216926

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  9 in total

1.  Perlecan regulates Oct-1 gene expression in vascular smooth muscle cells.

Authors:  M C Weiser; N A Grieshaber; P E Schwartz; R A Majack
Journal:  Mol Biol Cell       Date:  1997-06       Impact factor: 4.138

Review 2.  Impact of venous thromboembolism and anticoagulation on cancer and cancer survival.

Authors:  Nicole M Kuderer; Thomas L Ortel; Charles W Francis
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

3.  Heparin regulates colon cancer cell growth through p38 mitogen-activated protein kinase signalling.

Authors:  G Chatzinikolaou; D Nikitovic; A Berdiaki; A Zafiropoulos; P Katonis; N K Karamanos; G N Tzanakakis
Journal:  Cell Prolif       Date:  2009-10-21       Impact factor: 6.831

Review 4.  Pleiotropic effects of heparins: does anticoagulant treatment increase survival in cancer patients?

Authors:  I García-Escobar; C Beato-Zambrano; J Muñoz Langa; E Brozos Vázquez; B Obispo Portero; D Gutiérrez-Abad; A J Muñoz Martín
Journal:  Clin Transl Oncol       Date:  2018-02-22       Impact factor: 3.405

5.  Heparin (GAG-hed) inhibits LCR activity of human papillomavirus type 18 by decreasing AP1 binding.

Authors:  Rita Villanueva; Néstor Morales-Peza; Irma Castelán-Sánchez; Enrique García-Villa; Rocio Tapia; Angel Cid-Arregui; Alejandro García-Carrancá; Esther López-Bayghen; Patricio Gariglio
Journal:  BMC Cancer       Date:  2006-08-31       Impact factor: 4.430

6.  The role of blood in early endometrial-peritoneal interactions in a syngeneic mouse model of endometriosis.

Authors:  Ayako Kobayashi; Masahiko Maegawa; Satoshi Yamamoto; Natsuyo Ugumori; Yuka Kasai; Anna Tani; Hirokazu Uemura; Akira Kuwahara; Toshiya Matsuzaki; Toshiyuki Yasui; Hiroyuki Furumoto; Masaharu Kamada; Minoru Irahara
Journal:  Reprod Med Biol       Date:  2010-09-02

7.  Durable endothelium-mimicking coating for surface bioengineering cardiovascular stents.

Authors:  Qing Ma; Xiuying Shi; Xing Tan; Rui Wang; Kaiqin Xiong; Manfred F Maitz; Yuanyuan Cui; Zhangmei Hu; Qiufen Tu; Nan Huang; Li Shen; Zhilu Yang
Journal:  Bioact Mater       Date:  2021-05-24

Review 8.  Mechanisms simultaneously regulate smooth muscle proliferation and differentiation.

Authors:  Ning Shi; Shi-You Chen
Journal:  J Biomed Res       Date:  2013-12-28

9.  Heparin regulates B6FS cell motility through a FAK/actin cytoskeleton axis.

Authors:  Kallirroi Voudouri; Dragana Nikitovic; Aikaterini Berdiaki; Dionysios J Papachristou; John Tsiaoussis; Demetrios A Spandidos; Aristides M Tsatsakis; George N Tzanakakis
Journal:  Oncol Rep       Date:  2016-08-30       Impact factor: 3.906

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.